TissGDB

Home

	TissGeneSummary
	TissGeneExp
	TissGene-miRNA
	TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions
	TissGeneNet
	TissGeneProg
	TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for GATA3

Gene summary

Basic gene information	Gene symbol	GATA3
	Gene name	GATA binding protein 3
	Synonyms	HDR\|HDRS
	Cytomap	UCSC genome browser: 10p15
	Type of gene	protein-coding
	RefGenes	NM_001002295.1, NM_002051.2,
	Description	GATA-binding factor 3trans-acting T-cell-specific transcription factor GATA-3
	Modification date	20141222
dbXrefs	MIM : 131320
	HGNC : HGNC
	Ensembl : ENSG00000107485
	HPRD : 00572
	Vega : OTTHUMG00000017640
Protein	UniProt: go to UniProt's Cross Reference DB Table
Expression	CleanEX: HS_GATA3
	BioGPS: 2625
Pathway	NCI Pathway Interaction Database: GATA3
	KEGG: GATA3
	REACTOME: GATA3
	Pathway Commons: GATA3
Context	iHOP: GATA3
	ligand binding site mutation search in PubMed: GATA3
	UCL Cancer Institute: GATA3
Assigned class in TissGDB*	C
Included tissue-specific gene expression resources	TiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)	BladderSkin
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)	BLCASKCM
Reference showing the relevant tissue of GATA3
Description by TissGene annotations	Cancer gene

* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez

GO ID	GO term	PubMed ID
GO:0033600	negative regulation of mammary gland epithelial cell proliferation	19483726
GO:0045893	positive regulation of transcription, DNA-templated	19723756
GO:0045944	positive regulation of transcription from RNA polymerase II promoter	19232384
GO:0060231	mesenchymal to epithelial transition	20189993
GO:0072676	lymphocyte migration	19805038
GO:2000664	positive regulation of interleukin-5 secretion	20554961
GO:2000667	positive regulation of interleukin-13 secretion	20554961
GO:0033600	negative regulation of mammary gland epithelial cell proliferation	19483726
GO:0045893	positive regulation of transcription, DNA-templated	19723756
GO:0045944	positive regulation of transcription from RNA polymerase II promoter	19232384
GO:0060231	mesenchymal to epithelial transition	20189993
GO:0072676	lymphocyte migration	19805038
GO:2000664	positive regulation of interleukin-5 secretion	20554961
GO:2000667	positive regulation of interleukin-13 secretion	20554961

Top

TissGeneExp for GATA3

Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)

Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)

Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.

Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)

Cancer type	Mean(exp) in tumor	Mean(exp) in matched normal	Log2FC	P-val.	FDR
LIHC	-2.886548473	-1.381328473	-1.50522	1.74E-06	8.76E-06
KIRC	-1.286427028	3.176135472	-4.4625625	7.38E-48	5.34E-46
KIRP	-2.058055848	3.366575402	-5.42463125	1.26E-13	2.41E-12
PRAD	-0.02701955	2.007870835	-2.034890385	1.10E-10	2.35E-09
BRCA	5.447503527	3.905131597	1.54237193	4.11E-10	1.51E-09
ESCA	-1.004887382	-2.926560109	1.921672727	0.0028	0.027553982
KICH	1.649571527	3.173439527	-1.523868	0.00164	0.003409962
STAD	-0.404018348	-1.681802723	1.277784375	6.36E-05	0.000529764

Top

TissGene-miRNA for GATA3

Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))

Cancer type

miRNA id

miRNA accession

P-val.

Coeff.

# samples

Top

TissGeneMut for GATA3

TissGeneSNV for GATA3

nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
* Click on the image to enlarge it in a new window.

Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

- nsSNVs sorted by frequency.

AAchange	Cancer type	# samples
p.A395T	STAD	2
p.S408L	SKCM	2
p.M442I	LUAD	2
p.M443I	LUAD	2
p.K374N	TGCT	1
p.K185E	HNSC	1
p.G100D	PAAD	1
p.D336H	LUAD	1
p.H200Q	LUAD	1
p.T418M	COAD	1
p.T272N	SARC	1
p.F385V	STAD	1
p.W112*	SKCM	1
p.P163L	COAD	1
p.L50H	HNSC	1
p.S67*	LUSC	1
p.P436R	LUSC	1
p.M294K	BRCA	1
p.T323S	LUAD	1
p.A146T	READ	1
p.M357V	LGG	1
p.A102T	SKCM	1
p.P165T	LUSC	1
p.V161I	DLBC	1
p.G128W	LUAD	1
p.G278S	LUAD	1
p.S407L	SKCM	1
p.R399*	LUAD	1
p.S427F	SKCM	1
p.M205I	STAD	1
p.S12N	ESCA	1
p.I122T	COAD	1
p.A109T	STAD	1
p.G128V	CHOL	1
p.A268E	LUAD	1
p.A441T	STAD	1
p.S243F	SKCM	1
p.A396T	BLCA	1
p.T315M	COAD	1
p.R313K	UCEC	1
p.P409H	OV	1
p.A442T	STAD	1
p.A176D	HNSC	1
p.T120M	CHOL	1
p.A269E	LUAD	1
p.G128R	STAD	1
p.S138F	BLCA	1
p.G443C	ACC	1
p.A255T	DLBC	1
p.R331K	BRCA	1
p.S213L	BLCA	1
p.R365S	BRCA	1
p.S428R	SKCM	1
p.S391L	BLCA	1
p.G128E	SKCM	1
p.P135L	BLCA	1
p.G444C	ACC	1
p.L150P	LGG	1
p.K119M	BRCA	1
p.G81E	SKCM	1
p.S407W	HNSC	1
p.T108S	LUSC	1
p.R298Q	COAD	1
p.L97Q	HNSC	1
p.S230R	PAAD	1
p.A395T	PAAD	1
p.S408L	KIRC	1
p.P44L	UCS	1
p.C285Y	HNSC	1
p.E228K	STAD	1
p.P163L	UCEC	1
p.P409H	BRCA	1
p.T420M	STAD	1
p.M205I	READ	1
p.A395T	COAD	1
p.T326A	UCEC	1
p.S199F	OV	1
p.A396T	PAAD	1
p.R202H	STAD	1
p.D192N	LGG	1
p.A319E	KIRP	1
p.D335H	LUAD	1
p.P300T	LIHC	1
p.G21R	ESCA	1
p.C375X	COAD	1
p.M369I	LUSC	1
p.Q56H	ESCA	1
p.G279S	LUAD	1
p.R367Q	SKCM	1
p.N393I	OV	1
p.M294R	BRCA	1
p.K303N	LUAD	1
p.T421M	STAD	1
p.S426F	SKCM	1
p.G343E	SKCM	1
p.S142L	HNSC	1
p.S140F	SKCM	1
p.S118F	LUSC	1

Top

TissGeneCNV for GATA3

Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)

Top

TissGeneFusions for GATA3

Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)

Database	Src	Cancer type	Sample	Fusion gene	ORF	5'-gene BP	3'-gene BP
Chimerdb3.0	FusionScan	BRCA	TCGA-AR-A1AP-01A	GATA3-TAF3	In-Frame	chr10:8111561	chr10:8055693
Chimerdb3.0	TopHat-Fusion	BRCA	TCGA-AR-A1AP-01A	GATA3-TAF3	In-Frame	chr10:8111560	chr10:8055693
TCGAfusionPortal	PRADA	BRCA	TCGA-AR-A1AP-01A	GATA3-TAF3	In-frame	Chr10:8111561	Chr10:8055694

Top

TissGeneNet for GATA3

Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)

BRCA (tumor)	BRCA (normal)
GATA3, ELAVL1, UBC, MDM2, ETS1, HDAC3, VIP, RARB, CYBB, HDAC4, LMO2, EPO, CD8A, MUC1, ZFPM2, TAL1, GNRHR, FCGR2A, GYPE, KLRC1, LMO1 (tumor)	GATA3, ELAVL1, SP1, MDM2, SATB1, ETS2, ETS1, AR, RARB, CYBB, HDAC4, CD8A, MUC1, IL13, GNRHR, CGA, FCGR2A, REPIN1, TBX21, KLRC1, LMO1 (normal)

COAD (tumor)	COAD (normal)
GATA3, UBC, SP1, SATB1, ETS1, VIP, AR, RARB, CYBB, HDAC4, NFATC2, IL4, CD8A, MUC1, IL13, ZFPM2, TAL1, GNRHR, REPIN1, TBX21, LMO1 (tumor)	GATA3, ELAVL1, ETS2, ETS1, CREB1, HDAC5, VIP, AR, RARB, CYBB, NFATC2, LMO2, CD8A, IL13, ZFPM2, TAL1, CGA, FCGR2A, TBX21, GYPE, KLRC1 (normal)

HNSC (tumor)	HNSC (normal)
GATA3, UBC, MDM2, SATB1, ETS2, ETS1, HDAC3, RARB, CYBB, HDAC4, NFATC2, EPO, CD8A, GNRHR, CGA, FCGR2A, REPIN1, TBX21, HSD17B1, GYPE, KLRC1 (tumor)	GATA3, ELAVL1, SATB1, ETS1, AR, RARB, CYBB, NFATC2, LMO2, IL5, CD8A, MED1, IL13, ZFPM2, TAL1, CGA, FCGR2A, TBX21, HSD17B1, GYPE, KLRC1 (normal)

KICH (tumor)	KICH (normal)
GATA3, SATB1, ETS2, ETS1, HDAC3, VIP, AR, RARB, CYBB, HDAC4, LMO2, CD8A, IL13, ZFPM2, TAL1, GNRHR, FCGR2A, REPIN1, TBX21, HSD17B1, LMO1 (tumor)	GATA3, SP1, ETS1, HDAC3, CREB1, VIP, RARB, CYBB, LMO2, IL4, CD8A, MUC1, ZFPM2, TAL1, GNRHR, FCGR2A, TBX21, HSD17B1, GYPE, KLRC1, LMO1 (normal)

KIRC (tumor)	KIRC (normal)
GATA3, ELAVL1, SATB1, ETS1, HDAC5, VIP, AR, RARB, CYBB, EPO, IL5, CD8A, MED1, MUC1, ZFPM2, FCGR2A, REPIN1, TBX21, HSD17B1, KLRC1, LMO1 (tumor)	GATA3, ELAVL1, SP1, MDM2, ETS2, HDAC3, HDAC5, AR, EPO, IL4, IL5, CD8A, MED1, MUC1, IL13, ZFPM2, CGA, TBX21, HSD17B1, KLRC1, LMO1 (normal)

KIRP (tumor)	KIRP (normal)
GATA3, ELAVL1, ETS2, ETS1, HDAC3, HDAC5, VIP, AR, RARB, CYBB, LMO2, EPO, MUC1, IL13, ZFPM2, CGA, FCGR2A, REPIN1, HSD17B1, KLRC1, LMO1 (tumor)	GATA3, UBC, SP1, ETS2, ETS1, CREB1, VIP, AR, HDAC4, NFATC2, LMO2, CD8A, MUC1, TAL1, CGA, FCGR2A, REPIN1, TBX21, GYPE, KLRC1, LMO1 (normal)

LIHC (tumor)	LIHC (normal)
GATA3, SP1, SATB1, ETS1, HDAC3, CREB1, HDAC5, RARB, CYBB, NFATC2, LMO2, CD8A, MED1, MUC1, ZFPM2, TAL1, GNRHR, FCGR2A, REPIN1, TBX21, GYPE (tumor)	GATA3, SATB1, ETS1, CREB1, VIP, AR, RARB, CYBB, NFATC2, LMO2, EPO, IL5, CD8A, MUC1, ZFPM2, TAL1, FCGR2A, REPIN1, TBX21, GYPE, KLRC1 (normal)

LUAD (tumor)	LUAD (normal)
GATA3, UBC, SP1, MDM2, SATB1, ETS2, CREB1, HDAC5, VIP, AR, RARB, NFATC2, LMO2, MUC1, IL13, TAL1, CGA, FCGR2A, REPIN1, TBX21, GYPE (tumor)	GATA3, UBC, SP1, SATB1, ETS1, RARB, CYBB, NFATC2, LMO2, EPO, CD8A, MUC1, IL13, ZFPM2, TAL1, FCGR2A, REPIN1, TBX21, HSD17B1, GYPE, KLRC1 (normal)

LUSC (tumor)	LUSC (normal)
GATA3, UBC, SP1, MDM2, SATB1, ETS2, CREB1, HDAC5, AR, RARB, CYBB, NFATC2, LMO2, CD8A, IL13, ZFPM2, GNRHR, FCGR2A, TBX21, GYPE, KLRC1 (tumor)	GATA3, SP1, SATB1, ETS1, AR, RARB, CYBB, HDAC4, NFATC2, LMO2, CD8A, MUC1, ZFPM2, TAL1, CGA, FCGR2A, TBX21, HSD17B1, GYPE, KLRC1, LMO1 (normal)

PRAD (tumor)	PRAD (normal)
GATA3, ELAVL1, UBC, SP1, SATB1, ETS2, HDAC3, CREB1, AR, RARB, CYBB, LMO2, IL5, MUC1, GNRHR, CGA, FCGR2A, REPIN1, TBX21, GYPE, LMO1 (tumor)	GATA3, ELAVL1, SATB1, ETS2, ETS1, HDAC5, AR, RARB, CYBB, NFATC2, LMO2, IL4, CD8A, MUC1, ZFPM2, TAL1, FCGR2A, REPIN1, TBX21, GYPE, KLRC1 (normal)

STAD (tumor)	STAD (normal)
GATA3, ELAVL1, SP1, SATB1, ETS1, CREB1, HDAC5, AR, CYBB, HDAC4, LMO2, IL5, CD8A, MUC1, ZFPM2, FCGR2A, REPIN1, TBX21, GYPE, KLRC1, LMO1 (tumor)	GATA3, SATB1, ETS2, ETS1, HDAC5, VIP, AR, RARB, CYBB, NFATC2, LMO2, CD8A, IL13, ZFPM2, TAL1, FCGR2A, REPIN1, TBX21, GYPE, KLRC1, LMO1 (normal)

THCA (tumor)	THCA (normal)
GATA3, ELAVL1, SATB1, ETS1, VIP, AR, CYBB, LMO2, IL5, CD8A, MED1, MUC1, IL13, ZFPM2, TAL1, FCGR2A, REPIN1, TBX21, HSD17B1, KLRC1, LMO1 (tumor)	GATA3, ELAVL1, SP1, ETS2, VIP, AR, RARB, CYBB, LMO2, IL4, CD8A, MUC1, IL13, TAL1, CGA, FCGR2A, REPIN1, TBX21, HSD17B1, KLRC1, LMO1 (normal)

Top

TissGeneProg for GATA3

Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image to enlarge it in a new window.

Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.

Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.

Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.

Top

TissGeneClin for GATA3

TissGeneDrug for GATA3

Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

TissGeneDisease for GATA3

Disease information associated with TissGene
(DisGeNet, 2016-06-01)

Disease ID	Disease name	# pubmeds	Source
umls:C0006142	Malignant neoplasm of breast	40	BeFree,GAD
umls:C0678222	Breast Carcinoma	36	BeFree
umls:C1840333	Barakat syndrome	24	BeFree,CLINVAR,CTD_human,MGD,ORPHANET,UNIPROT
umls:C0004096	Asthma	22	BeFree,GAD,RGD
umls:C0020626	Hypoparathyroidism	22	BeFree,LHGDN
umls:C1458155	Mammary Neoplasms	14	BeFree,LHGDN
umls:C0235831	Renal Cell Dysplasia	13	BeFree
umls:C3536714	Renal dysplasia	13	BeFree
umls:C0027627	Neoplasm Metastasis	11	BeFree
umls:C0596263	Carcinogenesis	9	BeFree
umls:C0019829	Hodgkin Disease	5	BeFree,CTD_human,GAD,GWASCAT
umls:C2607914	Allergic rhinitis (disorder)	5	BeFree,GAD
umls:C0003873	Rheumatoid Arthritis	4	BeFree,CTD_human,GWASCAT
umls:C0011053	Deafness	4	LHGDN
umls:C0011615	Dermatitis, Atopic	4	BeFree,GAD,LHGDN
umls:C0018784	Sensorineural Hearing Loss (disorder)	4	BeFree
umls:C0155877	Allergic asthma	4	BeFree
umls:C0178874	Tumor Progression	4	BeFree
umls:C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	4	GAD,GWASCAT
umls:C0011570	Mental Depression	3	BeFree
umls:C0011581	Depressive disorder	3	BeFree
umls:C0013595	Eczema	3	BeFree
umls:C0021053	Immune System Diseases	3	BeFree
umls:C0024141	Lupus Erythematosus, Systemic	3	BeFree,LHGDN
umls:C0266292	Congenital anomaly of the kidney	3	BeFree
umls:C0000768	Congenital Abnormality	2	BeFree
umls:C0002874	Aplastic Anemia	2	BeFree,LHGDN
umls:C0005684	Malignant neoplasm of urinary bladder	2	BeFree,GAD
umls:C0007134	Renal Cell Carcinoma	2	BeFree
umls:C0007138	Carcinoma, Transitional Cell	2	BeFree
umls:C0009324	Ulcerative Colitis	2	BeFree
umls:C0011603	Dermatitis	2	BeFree
umls:C0011849	Diabetes Mellitus	2	BeFree,GAD
umls:C0015625	Fanconi Anemia	2	BeFree
umls:C0020523	Immediate hypersensitivity	2	GAD
umls:C0021367	Mammary Ductal Carcinoma	2	BeFree
umls:C0024299	Lymphoma	2	BeFree,LHGDN
umls:C0027819	Neuroblastoma	2	BeFree
umls:C0033860	Psoriasis	2	BeFree
umls:C0035455	Rhinitis	2	BeFree,GAD,LHGDN
umls:C0036421	Systemic Scleroderma	2	BeFree
umls:C0079774	Peripheral T-Cell Lymphoma	2	BeFree
umls:C0085129	Bronchial Hyperreactivity	2	GAD,RGD
umls:C0153676	Secondary malignant neoplasm of lung	2	BeFree
umls:C0155552	Hearing Loss, Mixed Conductive-Sensorineural	2	BeFree
umls:C0242379	Malignant neoplasm of lung	2	BeFree,GAD
umls:C0302592	Cervix carcinoma	2	BeFree
umls:C0376358	Malignant neoplasm of prostate	2	BeFree
umls:C0521158	Recurrent tumor	2	BeFree
umls:C0600139	Prostate carcinoma	2	BeFree
umls:C0684249	Carcinoma of lung	2	BeFree
umls:C0686619	Secondary malignant neoplasm of lymph node	2	BeFree
umls:C0700095	Central neuroblastoma	2	BeFree
umls:C0853879	Invasive breast carcinoma	2	BeFree
umls:C2145472	Urothelial Carcinoma	2	BeFree
umls:C3469521	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	2	BeFree
umls:C0002171	Alopecia Areata	1	BeFree
umls:C0002622	Amnesia	1	BeFree
umls:C0004943	Behcet Syndrome	1	BeFree
umls:C0006274	Bronchiolitis, Viral	1	GAD
umls:C0007112	Adenocarcinoma of prostate	1	BeFree
umls:C0007137	Squamous cell carcinoma	1	BeFree
umls:C0007570	Celiac Disease	1	BeFree
umls:C0007787	Transient Ischemic Attack	1	BeFree
umls:C0009319	Colitis	1	BeFree
umls:C0010278	Craniosynostosis	1	BeFree
umls:C0011311	Dengue Fever	1	BeFree
umls:C0011847	Diabetes	1	BeFree
umls:C0011854	Diabetes Mellitus, Insulin-Dependent	1	BeFree
umls:C0014072	Experimental Autoimmune Encephalomyelitis	1	BeFree
umls:C0018213	Graves Disease	1	BeFree
umls:C0019100	Severe Dengue	1	BeFree
umls:C0020522	Delayed Hypersensitivity	1	RGD
umls:C0021368	Inflammation	1	CTD_human
umls:C0021400	Influenza	1	BeFree
umls:C0022104	Irritable Bowel Syndrome	1	BeFree
umls:C0023452	Leukemia, Lymphocytic, Acute, L1	1	BeFree
umls:C0023485	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	1	CTD_human
umls:C0023493	Adult T-Cell Lymphoma/Leukemia	1	CTD_human
umls:C0024117	Chronic Obstructive Airway Disease	1	GAD
umls:C0024131	Lupus Vulgaris	1	BeFree
umls:C0024138	Lupus Erythematosus, Discoid	1	BeFree
umls:C0024143	Lupus Nephritis	1	BeFree
umls:C0024667	Animal Mammary Neoplasms	1	CTD_human
umls:C0024668	Mammary Neoplasms, Experimental	1	CTD_human
umls:C0026691	Mucocutaneous Lymph Node Syndrome	1	BeFree
umls:C0027430	Nasal Polyps	1	BeFree
umls:C0027697	Nephritis	1	BeFree
umls:C0030297	Pancreatic Neoplasm	1	LHGDN
umls:C0031099	Periodontitis	1	BeFree
umls:C0031106	Periodontitis, Juvenile	1	BeFree
umls:C0031154	Peritonitis	1	BeFree
umls:C0032285	Pneumonia	1	BeFree
umls:C0033578	Prostatic Neoplasms	1	BeFree
umls:C0035235	Respiratory Syncytial Virus Infections	1	GAD
umls:C0035457	Rhinitis, Allergic, Perennial	1	GAD
umls:C0037274	Dermatologic disorders	1	BeFree
umls:C0038356	Stomach Neoplasms	1	LHGDN
umls:C0038454	Cerebrovascular accident	1	BeFree,GAD
umls:C0042065	Genitourinary Neoplasms	1	BeFree
umls:C0042170	Uveomeningoencephalitic Syndrome	1	BeFree
umls:C0079772	T-Cell Lymphoma	1	BeFree
umls:C0085859	Polyglandular Type I Autoimmune Syndrome	1	BeFree
umls:C0152013	Adenocarcinoma of lung (disorder)	1	BeFree
umls:C0206180	Ki-1+ Anaplastic Large Cell Lymphoma	1	BeFree
umls:C0206708	Cervical Intraepithelial Neoplasia	1	BeFree
umls:C0220647	Carcinoma of unknown primary	1	BeFree
umls:C0240035	Interstitial fibrosis	1	BeFree
umls:C0262985	Psoriasiform eczema	1	BeFree
umls:C0266295	Congenital hypoplasia of kidney	1	BeFree
umls:C0270823	Petit mal status	1	BeFree
umls:C0275522	Asymptomatic Infections	1	BeFree
umls:C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	1	BeFree
umls:C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	1	BeFree
umls:C0345904	Malignant neoplasm of liver	1	BeFree
umls:C0346153	Breast Cancer, Familial	1	BeFree
umls:C0349458	Cervical intraepithelial neoplasia grade 1	1	BeFree
umls:C0349459	Cervical intraepithelial neoplasia grade 2	1	BeFree
umls:C0375023	Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	1	BeFree
umls:C0403367	proliferative nephritis unspecified	1	BeFree
umls:C0403601	Transplant glomerulopathy	1	BeFree
umls:C0409974	Lupus Erythematosus	1	BeFree
umls:C0432306	Ichthyosis Bullosa of Siemens	1	BeFree
umls:C0476227	pricking of skin	1	BeFree
umls:C0598766	Leukemogenesis	1	BeFree
umls:C0598935	Tumor Initiation	1	BeFree
umls:C0699885	Carcinoma of bladder	1	BeFree
umls:C0729552	Genital infection	1	BeFree
umls:C0751295	Memory Loss	1	BeFree
umls:C0795836	Chromosome 10, monosomy 10p	1	BeFree
umls:C0851140	Carcinoma in situ of uterine cervix	1	BeFree
umls:C1290884	Inflammatory disorder	1	BeFree
umls:C1332225	Aggressive Non-Hodgkin Lymphoma	1	BeFree
umls:C1333064	Classical Hodgkin's Lymphoma	1	BeFree
umls:C1336745	Thymic Lymphoma	1	BeFree
umls:C1527249	Colorectal Cancer	1	GWASCAT
umls:C1561535	Creatinine finding	1	GAD
umls:C1709246	Non-Neoplastic Disorder	1	BeFree
umls:C1854365	BREAST CANCER 3	1	BeFree
umls:C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	1	BeFree
umls:C2239176	Liver carcinoma	1	BeFree
umls:C3539878	Triple Negative Breast Neoplasms	1	BeFree
umls:C3809874	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3	0	ORPHANET